CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Shire Canada Inc. v. Natco Pharma Limited

1:09-cv-03165

Overview

Case Number 1:09-cv-03165
Filing Date 2009-04-01
Status Terminated
Termination Date 2013-03-29
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Natco Pharma Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Mylan Pharmaceuticals Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Barr Laboratories, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Shire US Inc. Operating Company

Represented By

1 Attorneys Listed

Shire International Licensing B.V. Operating Company

Represented By

1 Attorneys Listed

Counter Claimant

Mylan Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Counter Defendant

Shire Canada Inc. Operating Company

Represented By

1 Attorneys Listed

Matrix Laboratories Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7465465
Pharmaceutical formulation comprising lanthanum compounds
Filed: 2004-08-26
Issued: 2008-12-16
Expired (Term Ended) +44d PTA
Expires: 2024-10-09

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

24

Dispositive

13

Granted

2

Denied

1

Pending / Review

21

Motions by Category

Motion for Preliminary Injunction / TRO 13 Claim Construction / Markman Filing 11

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending / Under Review
STIPULATED DISMISSAL OF ACTION: Pursuant to Rule 41(a)(1)(A)(ii) of the Federal Rules of Civil Procedures, the parties and/or their respective counsel(s), hereb...
Entry #103 • 2013-03-29 Document →
Motion for Preliminary Injunction / TRO Denied
ORDER denying 68 Motion for Reconsideration. As the defendant has failed to identify "matters or controlling decisions which...the court has overlooked," see Lo...
Entry #94 • 2010-05-26 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
JOINT APPENDIX OF INTRINSIC AND EXTRINSIC EVIDENCE: VOLUME IV (JA 1852-JA2475). Document filed by Shire Canada Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Mat...
Entry #88 • 2010-05-18 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
JOINT APPENDIX OF INTRINSIC AND EXTRINSIC EVIDENCE: VOLUME V (JA 2476-JA 3295). Document filed by Shire Canada Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Mat...
Entry #89 • 2010-05-18 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
JOINT APPENDIX OF INTRINSIC AND EXTRINSIC EVIDENCE: VOLUME VI (JA 3296- JA 4083). Document filed by Shire Canada Inc., Mylan Inc., Mylan Pharmaceuticals Inc., M...
Entry #90 • 2010-05-18 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
JOINT APPENDIX OF INTRINSIC AND EXTRINSIC EVIDENCE: VOLUME VII (JA 4084- JA 4893) Document filed by Shire Canada Inc., Mylan Inc., Mylan Pharmaceuticals Inc., M...
Entry #91 • 2010-05-18 Document →

Docket Entries

(107 total)
Pleading / Complaint

COMPLAINT against Natco Pharma Limited. (Filing Fee $ 350.00, Receipt Number 683120)Document filed by Shire Canada Inc., Shire International Licensing B.V., Shire US Inc.(ama) (Entered: 04/03/2009)

Entry #1 • 2009-04-01
1

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Shire plc, Shire Pharmaceutical Holdings Ireland Ltd, Shire Biopharmaceuticals Holdings, Shire holdings UK Canada Ltd, Shire Acqusition Inc. as Corporate Parent. Document filed by Shire Canada Inc., Shire International Licensing B.V., Shire US Inc.(ama) (Entered: 04/03/2009)

Entry #2 • 2009-04-01
1

NOTICE OF CASE ASSIGNMENT to Judge Paul G. Gardephe. (rdz) (Entered: 04/08/2009)

Entry #3 • 2009-04-07
1
Pleading / Complaint

AFFIDAVIT OF SERVICE of Summons and Complaint. Natco Pharma Limited served on 4/8/2009, answer due 4/28/2009. Document filed by Shire Canada Inc.; Shire International Licensing B.V.; Shire US Inc.. (Lumelsky, Anna) (Entered: 04/08/2009)

Entry #4 • 2009-04-08
1
Motion for Preliminary Injunction / TRO Pending / Under Review

NOTICE OF PRETRIAL CONFERENCE: Initial Conference set for 5/8/2009 at 10:00 AM in Courtroom 18B, 500 Pearl Street, New York, NY 10007 before Judge Paul G. Gardephe. Principal trial counsel must appear at this and all subsequent conferences. (Signed by Judge Paul G. Gardephe on 4/13/09) (tro) (Entered: 04/13/2009)

Entry #5 • 2009-04-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc